TORONTO,
Canada and GLIL YAM, Israel, May 5, 2022
/PRNewswire/ -- IM Cannabis Corp. (the "Company" or "IM
Cannabis") (CSE: IMCC) (NASDAQ: IMCC), a leading medical and
adult-use recreational cannabis company with operations in
Israel, Canada, and Germany, will report operational and financial
results for the first quarter ended March
31, 2022 after market close on Thursday, May 12, 2022.
Management will host a conference call to discuss the results,
followed by a question-and-answer session from participants. To
participate, please use the following information:
Q1 2022 Conference Call
Date: Thursday, May 12, 2022
Time: 5:00 p.m. Eastern time
U.S./Canada Dial-in: 1-844-825-9789
Israel Dial-in: 1-80-9213284
Germany Dial-in: 0-800-5895393
International Dial-in: 1-412-317-5180
Conference ID: 10167199
Webcast: IMCC Q1 2022 Webcast
Please dial in at least 10 minutes before the start of the call
to ensure timely participation.
A playback of the call will be available through Thursday, June 9, 2022. To listen, call
1-844-512-2921 within the United
States or Canada or
1-412-317-6671 when calling internationally and enter replay pin
number 10167199. A recording of the conference call will also be
available on the events & presentations section of the IM
Cannabis investor relations website linked here.
About IM Cannabis Corp.
IM Cannabis (NASDAQ: IMCC, CSE: IMCC) is a leading international
cannabis company providing premium products to medical patients and
adult-use recreational consumers. IM Cannabis is one of the very
few companies with operations in Israel, Germany and Canada, the three largest federally legal
markets. The ecosystem created through its international operations
leverages the Company's unique data-driven perspective and product
supply chain globally. With its commitment to responsible growth
and financial prudence, and the ability to operate within the
strictest regulatory environments, the Company has quickly become
one of the leading cultivators and distributors of high-quality
cannabis globally.
The Company operates medical cannabis retail pharmacies, online
platforms, distribution centres and logistical hubs through IMC
Holdings Ltd. in Israel that
enable the safe delivery and quality control of IM Cannabis
products throughout the entire value chain. In Germany, the IM Cannabis ecosystem operates
through Adjupharm GmbH, where it also distributes cannabis to
pharmacies to medical cannabis patients. In Canada, IM Cannabis operates through Trichome
Financial Corp. and its subsidiaries TJAC and MYM, where it
cultivates and processes cannabis for the adult-use market at its
Ontario, Nova Scotia, and Quebec facilities under the WAGNERS and
Highland Grow brands.
Company Contact:
Maya Lustig, Director Investor & Public
Relations
IM Cannabis
+972-54-677-8100
maya.l@imcannabis.com
Investor Relations:
Brooks
Hamilton, Director
MZ Group – MZ North America
+1 949-546-6326
IMCC@mzgroup.us
View original
content:https://www.prnewswire.com/news-releases/im-cannabis-to-report-first-quarter-2022-financial-results-on-thursday-may-12-at-500-pm-et-301540657.html
SOURCE IM Cannabis Corp.